Search

Search Constraints

You searched for: Author/Creator Zhou, Tianxing

Search Results

2. ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4. Issue 2 (5th March 2021)